medigraphic.com
Colegio de Medicina Interna de México.

2024, Number 03

<< Back Next >>

Med Int Mex 2024; 40 (03)

Ten points to help classify patients with systemic lupus erythematosus

Mercado U

Language: Spanish
References: 12
Page: 221-226
PDF size: 181.87 Kb.


ABSTRACT

In 2019, the American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) proposed new criteria to aid classify a patient with systemic lupus erythematosus. These criteria use a point-based system ranging from 2-10 points. The presence of antinuclear antibody is an entry criterion for classification. Sensitivity and specificity are 93% and 96%, respectively. Non-infectious fever was added as the new criterion. VDRL and LE cell tests and photosensitivity have been removed.


REFERENCES

  1. Jog NR, James JA. Epstein-Barr virus and autoimmuneresponses in systemic lupus erythematosus. Front Immunol 2021; 11: 623944. doi: 10.3389/fimmu.2020.623944.

  2. Arbucle MR, McClain MT, Rubertone MV, Scofield RH,Dennis GJ, et al. Development of autoantibodies beforethe clinical onset of systemic lupus erythematosus. NEJM2003; 349: 1526-1533. DOI: 10.1056/NEJMoa021933.

  3. Shmerling RH. Perspective. Autoantibodies in systemiclupus erythematosus-there before you know it. N Engl JMed 2003; 349: 199-1500. doi: 10.1056/NEJMp038142.

  4. Deafen D, Escalante A, Weinrib L, Horwitz D, Bachman Bet al. A revised estimate of twin concordance in systemiclupus erythematosus. Arthritis Rheum 1992; 3: 311-8. doi:10.1002/art.1780350310.

  5. Sandhu V, Quan M. SLE and serum complement: causative,concomitant or coincidental? Open Rheumatol J 2017; 11:113-20. doi: 10.2174/1874312901711010113.

  6. Mercado U, Urquiza I. Virus de Epstein-Barr y lupus: ¿culpablepor asociación? Med Int Mex 2021; 37: 403-406.https://doi.org /10.24245/mim.v37i3.3840.

  7. Mercado U, Díaz-Molina R, Acosta H. Epstein-Barr virusand lupus. Curr Topics Virol 2010; 8: 59-61.

  8. Mercado U, Urquiza I, Guardado JA, Araiza-Casillas R. Lupuseritematoso sistémico en hombres. Med Int Mex 2021;37: 167-172. https://doi.org/10.24245/mim.v37i2.3681.

  9. Soto DR, Mercado U. Características clínicas e inmunológicasde lupus erithematoso sistémico aplicandolos criterios de clasificación de EULAR/ACR 2019. MedInt Mex 2022; 38: 507-513. https://doi.org/10.24245/mim.v38i3.5146.

  10. Thomas R, Jawad AS. Systemic lupus erythematosus: rarerin men than women but more severe. Trends UrologyMen’s Health 2022; 13: 11-14. https://doi.org/10.1002/tre.876.

  11. Manson JJ, Isenberg DA. The pathogenesis of systemiclupus erythematosus. Neth J Med 2003; 61: 343-6.

  12. Ohara A Iwata N, Sugiura S, Abe N, Nakaseko H, et al.Evaluation of the European League against Rheumatism/American College of Rheumatology-2019 classificationcriteria in patients with childhood-onset systemic lupuserythematosus: a single-center retrospective study. ClinRheumatol 2022; 41: 2483-2489. doi: 10.1007/s10067-022-06138-7.




2020     |     www.medigraphic.com